STOCK TITAN

Cresco Labs to Report Third Quarter 2024 Financial Results on November 8, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ), a leading cannabis company, has announced it will release its third quarter 2024 financial results on Friday, November 8th, 2024, before the market opens. The company will host a conference call and webcast on the same day at 8:30 am EST to discuss the results and provide key business highlights to investors.

Interested parties can access the earnings conference call via webcast or by dialing in. The US toll-free number is 1-833-470-1428, while the US local number is 1-404-975-4839, with the access code 435112. The webcast will be archived and available for one year on Cresco Labs' investor relations website.

Positive
  • None.
Negative
  • None.

CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the third quarter ended September 30th, 2024 on Friday, November 8th, 2024 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.

Event: Cresco Labs Third Quarter 2024 Earnings Conference Call
Date: Friday, November 8th, 2024
Time: 8:30 am EST
Webcast: LINK
Conference Call Registration: LINK
Dial-in: 1-833-470-1428 (US Toll Free), 1-404-975-4839 (US Local)
Access Code: 435112

Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.

About Cresco Labs Inc.

Cresco Labs’ mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production and branded product distribution, the Company is leveraging its scale and agility to grow its portfolio of brands that include Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s and Remedi, on a national level. The Company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering ongoing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, workforce development and legislative initiatives designed to create the most responsible, respectable and robust cannabis industry possible. Learn more about Cresco Labs’ journey by visiting www.crescolabs.com or following the Company on Facebook, X or LinkedIn.

Media

Jason Erkes, Chief Communications Officer

press@crescolabs.com

312-953-2767



Investors

investors@crescolabs.com



General Inquiries

312-929-0993

info@crescolabs.com

Source: Cresco Labs

FAQ

When will Cresco Labs (CRLBF) release its Q3 2024 financial results?

Cresco Labs (CRLBF) will release its third quarter 2024 financial results on Friday, November 8th, 2024, before the market opens.

What time is Cresco Labs' (CRLBF) Q3 2024 earnings conference call?

Cresco Labs' (CRLBF) third quarter 2024 earnings conference call is scheduled for Friday, November 8th, 2024, at 8:30 am EST.

How can investors access Cresco Labs' (CRLBF) Q3 2024 earnings call?

Investors can access Cresco Labs' (CRLBF) Q3 2024 earnings call via webcast or by dialing 1-833-470-1428 (US Toll Free) or 1-404-975-4839 (US Local) with the access code 435112.

Where can I find the archived webcast of Cresco Labs' (CRLBF) Q3 2024 earnings call?

The archived webcast of Cresco Labs' (CRLBF) Q3 2024 earnings call will be available for one year on the company's investor relations website.

CRESCO LABS INC

OTC:CRLBF

CRLBF Rankings

CRLBF Latest News

CRLBF Stock Data

593.77M
327.23M
0.66%
7.85%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Chicago